Estimates suggest that the United States comprises up to 80% of total global medical innovation. This is because the U.S. has a unique lack of price regulation on drugs, allowing pharmaceutical companies to thrive. However, leaders across the political spectrum including Clinton, Sanders, and Trump have been proposing the implementation of price controls on the pharmaceutical industry to slow rising drug prices.
Offshore Tax Havens
The collective decision to integrate within the global economic system, like the revocation of the mercantilist Corn Laws in 1846 (Kevin O’Rourke, 1999), propelled states further into interdependency and drastically improved their economies.
